From: Gene polymorphisms in association with emerging cardiovascular risk markers in adult women
 | Percent (Standard Error) |
---|---|
 | N = 3,409 |
Age | Â |
17-40 | 45.6 (1.8) |
41-59 | 30.2 (1.6) |
60+ | 24.2 (2.2) |
Race/Ethnicity | Â |
   Non-Hispanic white | 81.3 (1.8) |
   Non-Hispanic black | 13.2 (1.7) |
   Mexican American | 5.6 (0.8) |
Educational attainment | Â |
   < 12 yrs | 22.1 (1.6) |
   12 yrs | 37.5 (1.4) |
   College or above | 40.4 (2.4) |
BMI (kg/m2) | Â |
   < 25 | 48.1 (1.9) |
   25-29.9 | 25.4 (0.8) |
   ≥ 30 | 26.5 (1.4) |
Smoking status | Â |
   Current smoker | 25.7 (1.5) |
   Former smoker | 18.7 (1.4) |
   Never smoker | 55.6 (1.8) |
Drinking status | Â |
   Lifetime abstainer | 17.9 (1.7) |
   Former drinker | 38.8 (1.3) |
   Current drinker | 43.3 (2.2) |
Total dietary fiber intake | Â |
   ≥ 7 gm/1000 kcal | 59.8 (1.9) |
   < 7 gm/1000 kcal | 40.2 (1.9) |
Total energy intake | Â |
   ≥ 1600 kcal | 56.4 (1.4) |
   < 1600 kcal | 43.6 (1.4) |
Physical activity | Â |
   None | 22.7 (2.1) |
   Low | 35.3 (1.1) |
   High | 42.0 (1.9) |
Menopausal status | Â |
   Yes | 40.7 (2.2) |
   No | 59.3 (2.2) |
Aspirin use | Â |
   None | 68.0 (1.2) |
   < 1 day/month | 30.1 (1.1) |
   ≥ 1 day/month | 1.8 (0.4) |
Female hormone use | Â |
   Yes | 16.0 (1.4) |
   No | 84.0 (1.4) |
Serum C-reactive protein (mg/dL)a | 0.33 (0.31,0.35) |
Plasma fibrinogen (g/L)a | 3.00 (2.95, 3.06) |
Serum homocysteine (umol/L)a | 8.17 (8.01, 8.33) |
Serum uric acid (umol/L)a | 270 (265, 276) |